• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number 1973-03
Device Problem Deflation Problem (1149)
Patient Problems Foreign Body In Patient (2687); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/11/2022
Event Type  Injury  
Event Description
It was reported that the balloon would not deflate, and some balloon material was left in the patient.A 7.0mm x 40mm, 135cm ranger paclitaxel-coated pta balloon catheter was selected for use in a peripheral intervention of the external iliac artery.During the procedure, the balloon was inflated at 8atm for three minutes, but the balloon would deflate following dilation.A needle was used to pop the balloon, but some of the balloon material was left inside the patient.The patient was taken to the or to open up the artery and retrieve the rest of the device.The procedure was not completed.No further patient complications were reported.
 
Event Description
It was reported that the balloon would not deflate, and some balloon material was left in the patient.A 7.0mm x 40mm, 135cm ranger paclitaxel-coated pta balloon catheter was selected for use in a peripheral intervention of the external iliac artery.During the procedure, the balloon was inflated at 8atm for three minutes, but the balloon would deflate following dilation.A needle was used to pop the balloon, but some of the balloon material was left inside the patient.The patient was taken to the or to open up the artery and retrieve the rest of the device.The procedure was not completed.No further patient complications were reported.It was further reported that the target lesion was moderately calcified, and all device fragments were successfully retrieved.The patient was fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Type of Device
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15175693
MDR Text Key297341529
Report Number2134265-2022-08370
Device Sequence Number1
Product Code ONU
UDI-Device Identifier08714729976240
UDI-Public08714729976240
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P190019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/05/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/07/2024
Device Model Number1973-03
Device Catalogue Number1973-03
Device Lot Number02103H22
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/05/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/08/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-